Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

High versus low energy administration in the early phase of acute pancreatitis (GOULASH trial): protocol of a multicentre randomised double-blind clinical trial

Márta, Katalin, Szabó, Anikó N, Pécsi, Dániel, Varjú, Péter, Bajor, Judit, Gódi, Szilárd, Sarlós, Patrícia, Mikó, Alexandra, Szemes, Kata, Papp, Mária, Tornai, Tamás, Vincze, Áron, Márton, Zsolt, Vincze, Patrícia A, Lankó, Erzsébet, Szentesi, Andrea, Molnár, Tímea, Hágendorn, Roland, Faluhelyi, Nándor, Battyáni, István, Kelemen, Dezs?, Papp, Róbert, Miseta, Attila, Verzár, Zsófia, Lerch, Markus M, Neoptolemos, John P, Sahin-Tóth, Miklós, Petersen, Ole and Hegyi, Péter 2017. High versus low energy administration in the early phase of acute pancreatitis (GOULASH trial): protocol of a multicentre randomised double-blind clinical trial. BMJ Open 7 (9) , e015874. 10.1136/bmjopen-2017-015874

[thumbnail of e015874.full.pdf]
PDF - Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (682kB) | Preview


Introduction Acute pancreatitis (AP) is an inflammatory disease with no specific treatment. Mitochondrial injury followed by ATP depletion in both acinar and ductal cells is a recently discovered early event in its pathogenesis. Importantly, preclinical research has shown that intracellular ATP delivery restores the physiological function of the cells and protects from cell injury, suggesting that restoration of energy levels in the pancreas is therapeutically beneficial. Despite several high quality experimental observations in this area, no randomised trials have been conducted to date to address the requirements for energy intake in the early phase of AP. Methods/design This is a randomised controlled two-arm double-blind multicentre trial. Patients with AP will be randomly assigned to groups A (30 kcal/kg/day energy administration starting within 24 hours of hospital admission) or B (low energy administration during the first 72 hours of hospital admission). Energy will be delivered by nasoenteric tube feeding with additional intravenous glucose supplementation or total parenteral nutrition if necessary. A combination of multiorgan failure for more than 48 hours and mortality is defined as the primary endpoint, whereas several secondary endpoints such as length of hospitalisation or pain will be determined to elucidate more detailed differences between the groups. The general feasibility, safety and quality checks required for high quality evidence will be adhered to. Ethics and dissemination The study has been approved by the relevant organisation, the Scientific and Research Ethics Committee of the Hungarian Medical Research Council (55961-2/2016/EKU). This study will provide evidence as to whether early high energy nutritional support is beneficial in the clinical management of AP. The results of this trial will be published in an open access way and disseminated among medical doctors.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Biosciences
Publisher: BMJ Publishing Group
ISSN: 2044-6055
Date of First Compliant Deposit: 20 December 2017
Date of Acceptance: 25 July 2017
Last Modified: 20 Dec 2017 15:22

Citation Data

Cited 18 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics